A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP

By sjmartinez • November 29, 2022

Yu Y, Bigos KL, Marzinke MA, Landovitz RJ, McCauley M, Ford S, Hendrix CW, Bies RR, Weld ED; HPTN 077 Study Team. A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP. Br J Clin Pharmacol. 2022 Oct;88(10):4623-4632. doi: 10.1111/bcp.15477. Epub 2022 Aug 14. PMID: 35949044.

Tags: antiretrovirals, HIV/AIDS, Infectious Diseases, infectious diseases, pharmacometrics, Publications

Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle[...]

A New Approach to In Vivo Transformation of Killer T cells

Rodriguez N, Hofmann C, Yang OO, Gelbart WM. A New Approach to In Vivo Transformation of Killer T cells. J Mol Biol. 2025 Aug 1:169369.[...]

A peer-educator driven approach for sampling populations at increased mpox risk in the Democratic Republic of the Congo: Implications for surveillance and response

Merritt S, Halbrook M, Anta Y, Mukadi PK, Hasivirwe Vakaniaki E, Bodisa-Matamu T, Lunyanga L, Kacita C, Kompany JP, Makangara-Cigolo JC, Kenye M, Kavira S,[...]